THANK YOU FOR SUBSCRIBING
Medical Tech Outlook Weekly Brief
Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Medical Tech Outlook
Summary: ActiGraft intends to provide MediGroup’s members with a cheap and effective wound solution to help improve the health and lifestyles of patients with chronic, non-healing wounds.
FREMONT, CA
“We are honored to partner with MediGroup, a group purchasing organization that supports over 250,000 health care employees,” statesAlonKushnir, CEO of RedDress on RedDress, a privately held wound care company based in the United States and Israel, forming a partnership with MediGroup. MediGroup is one of the nation’s largest non-acute care group purchasing organizations representing physician centers, surgery centers, and specialty clinics. The collaboration aims at providing MediGroup members with its innovative wound care solution, the ActiGraft system.
“Through this new, strategic partnership, we will continue to deliver ActiGraft to health care providers at an affordable cost,” adds Kushnir.
ActiGraft intends to provide MediGroup’s members with a cheap and effective wound solution to help improve the health and lifestyles of patients with chronic, non-healing wounds. According to a reasonable estimate, the yearly cost of treating a wound when it is the principal claim is around 28 billion dollars, putting a considerable financial strain on the healthcare system, providers, and patients.
“Over the past 20 plus years, MediGroup has grown to provide our members with the most comprehensive portfolio that maximizes efficiencies and minimizes costs,” says MediGroups Chief Executive Officer, Andy Klearman. “We know our members will value RedDress advanced wound care products and skin substitutes for the treatment of chronic wounds in their practices and other patient settings.”
ActiGraft is the first wound care tool that allows doctors to create an in vitro blood clot from a patient’s blood in real-time. The blood clot acts as a protective layer and aids the body’s natural wound healing process once applied. ActiGraft can be used to treat diabetic foot ulcers, pressure injuries, venous ulcers, traumatic wounds, and post-surgical wounds, among other difficult-to-treat chronic wounds.
Read Also
